These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6967124)
1. Increased susceptibility to tumor cell immunosuppressive effect in tumor-bearing mice. Ting CC; Rodrigues D J Natl Cancer Inst; 1980 Jul; 65(1):205-9. PubMed ID: 6967124 [TBL] [Abstract][Full Text] [Related]
2. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. Ting CC; Rodrigues D J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653 [TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor. Ye QW; Mokyr MB Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201 [TBL] [Abstract][Full Text] [Related]
4. Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells. Bluestone JA; Lopez C J Natl Cancer Inst; 1979 Nov; 63(5):1221-7. PubMed ID: 228106 [TBL] [Abstract][Full Text] [Related]
5. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression. Ting CC; Hargrove ME J Natl Cancer Inst; 1982 Oct; 69(4):873-8. PubMed ID: 6214654 [TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages. Igarashi T; Teranishi T; Rodrigues D; Yamamura Y Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022 [TBL] [Abstract][Full Text] [Related]
8. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice. Young MR; Newby M J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925 [TBL] [Abstract][Full Text] [Related]
9. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement. Schultz RM; Woods WA; Mohr SJ; Chirigos MA Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825 [TBL] [Abstract][Full Text] [Related]
10. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. Watson GA; Lopez DM J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727 [TBL] [Abstract][Full Text] [Related]
11. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma. Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630 [TBL] [Abstract][Full Text] [Related]
12. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors. Rivera LM; Lopez DM Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569 [TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells. Ting CC; Rodrigues D J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645 [No Abstract] [Full Text] [Related]
15. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host. Hummel S; Wilms D; Vitacolonna M; Zöller M J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses. Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649 [TBL] [Abstract][Full Text] [Related]
17. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
18. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells. Przepiorka D; Mokyr MB; Dray S Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090 [TBL] [Abstract][Full Text] [Related]
19. Immunological activity of regional lymph nodes in tumor-bearing mice. Barna BP; Deodhar SD Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691 [TBL] [Abstract][Full Text] [Related]
20. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice. Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]